Dianthus Therapeutics (DNTH) FCF Margin (2022 - 2025)
Historic FCF Margin for Dianthus Therapeutics (DNTH) over the last 4 years, with Q3 2025 value amounting to 7717.17%.
- Dianthus Therapeutics' FCF Margin fell 67368800.0% to 7717.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 3561.63%, marking a year-over-year decrease of 23868600.0%. This contributed to the annual value of 1255.57% for FY2024, which is 526700.0% up from last year.
- Per Dianthus Therapeutics' latest filing, its FCF Margin stood at 7717.17% for Q3 2025, which was down 67368800.0% from 12403.11% recorded in Q2 2025.
- Over the past 5 years, Dianthus Therapeutics' FCF Margin peaked at 1399.91% during Q3 2022, and registered a low of 12403.11% during Q2 2025.
- In the last 4 years, Dianthus Therapeutics' FCF Margin had a median value of 1713.16% in 2024 and averaged 2600.64%.
- As far as peak fluctuations go, Dianthus Therapeutics' FCF Margin surged by 7129600bps in 2024, and later tumbled by -116223800bps in 2025.
- Over the past 4 years, Dianthus Therapeutics' FCF Margin (Quarter) stood at 755.74% in 2022, then tumbled by -269bps to 2784.98% in 2023, then increased by 26bps to 2072.02% in 2024, then crashed by -272bps to 7717.17% in 2025.
- Its last three reported values are 7717.17% in Q3 2025, 12403.11% for Q2 2025, and 2377.82% during Q1 2025.